Ma Gaoting, Yu Zequan, Jia Baixue, Xian Ying, Ren Zeguang, Mo Dapeng, Ma Ning, Gao Feng, Tong Xu, Shi Xiangqun, Li Ling, Pan Yuesong, Miao Zhongrong
Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, No.119, South 4th Ring West Road, 100070, Fengtai District, Beijing, China.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Clin Neuroradiol. 2022 Dec;32(4):997-1009. doi: 10.1007/s00062-022-01178-7. Epub 2022 May 27.
The benefit of endovascular reperfusion therapy for acute ischemic stroke is highly time-dependent but the relation of delays in workflow with outcomes and the key determinants of delays remain uncertain. This study aimed to evaluate the association between faster endovascular therapy and outcomes in a Chinese population with acute ischemic stroke.
Patients treated with endovascular therapy within 7 h due to anterior large vessel occlusion were enrolled in the ANGEL-ACT registry. Time intervals from hospital arrival to arterial puncture (door-to-puncture), hospital arrival to reperfusion (door-to-reperfusion) and puncture-to-reperfusion were recorded. The outcomes included modified Rankin Scale (mRS) scores 0-1, 0-2, mortality at 3 months, substantial reperfusion, and symptomatic intracranial hemorrhage (sICH).
Of 932 patients receiving endovascular therapy (mean age 65.1 years, 60.1% male), the median door-to-puncture, door-to-reperfusion, and puncture-to-perfusion times were 110min (interquartile range, IQR 72-155min), 200min (IQR, 149-260min), and 76min (IQR, 50-118min). Of the patients 87.4% achieved substantial reperfusion and 9.6% had sICH. The mRS 0-1, 0-2, and mortality at 3 months were 39.8%, 43.2%, and 16.4%. Faster door-to-reperfusion and puncture-to-reperfusion were associated with higher likelihood of mRS 0-1, mRS 0-2, and lower rate of sICH. There was a trend of improved mRS, lower mortality, and fewer ICH with shorter door-to-puncture time; however, most differences were not statistically significant.
Among patients with acute ischemic stroke in routine clinical practice, shorter time to reperfusion was associated with better outcome after endovascular therapy. Standardized workflows and training in endovascular treatment techniques should be promoted nationally to reduce in-hospital delays.
血管内再灌注治疗对急性缺血性卒中的益处高度依赖时间,但工作流程中的延迟与结局的关系以及延迟的关键决定因素仍不确定。本研究旨在评估在中国急性缺血性卒中患者中更快的血管内治疗与结局之间的关联。
因前循环大血管闭塞在7小时内接受血管内治疗的患者被纳入ANGEL-ACT注册研究。记录从入院到动脉穿刺(门到穿刺)、入院到再灌注(门到再灌注)以及穿刺到再灌注的时间间隔。结局指标包括改良Rankin量表(mRS)评分0-1、0-2、3个月时的死亡率、充分再灌注以及症状性颅内出血(sICH)。
在932例接受血管内治疗的患者中(平均年龄65.1岁,男性占60.1%),门到穿刺、门到再灌注以及穿刺到灌注时间的中位数分别为110分钟(四分位间距,IQR 72-155分钟)、200分钟(IQR,149-260分钟)和76分钟(IQR,50-118分钟)。87.4%的患者实现了充分再灌注,9.6%发生了sICH。mRS 0-1、0-2以及3个月时的死亡率分别为39.8%、43.2%和16.4%。更快的门到再灌注和穿刺到再灌注与mRS 0-1、mRS 0-2的更高可能性以及更低的sICH发生率相关。门到穿刺时间越短,mRS有改善、死亡率降低以及颅内出血减少的趋势;然而,大多数差异无统计学意义。
在常规临床实践的急性缺血性卒中患者中,再灌注时间越短,血管内治疗后的结局越好。应在全国推广标准化工作流程和血管内治疗技术培训,以减少院内延迟。